ApoE and Brain Networks—The Anatomy of a Risk Factor
story) trial data.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2455 Alzheimer's
379 RESULTS
You searched Esther
Sort By:
story) trial data.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2455 Alzheimer's
in the process, and not global Notch,” Brinton said.—Esther Landhuis None
of disease,” Robert Nagele told ARF.—Esther Landhuis None
PQN-41 to promote linker cell death.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3076
did not own. The patents at the center of this controversy expire next year.—Esther Landhuis. None
cholesterol but on the whole [mevalonate] pathway. The implications of that could be detrimental.”—Esther
compared to unaffected controls, suggesting it could serve as a disease biomarker, Abeliovich said.—Esther
non-convulsive epileptiform activity, Mucke reported.—Esther Landhuis. This is Part 3 of a three-part series.
wrote.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3579 Aging Histone
present.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3589 Alzheimer's Disease Aβ Glutamate
story).—Esther Landhuis None Immune Related Microglia/Astrocyte Growth Factors and Growth Factor Receptors
phospho-tau (ARF news story on Cruchaga et al., 2013). —Esther Landhuis Q&A With Lawrence Steinman.
ties between insulin signaling and Alzheimer disease.—Esther Landhuis. None
Australian biotech company that sponsored the trial.—Esther Landhuis None
the coming year.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2359 Alzheimer's